3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
2
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
20
Vitamin D Deficiency
17
Prostatic Neoplasms
14
Neoplasms
9
Polycystic Ovary Syndrome
8
Colonic Neoplasms
8
Rectal Neoplasms
6
Colorectal Neoplasms
6
Myelodysplastic Syndromes
5
Osteoporosis
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Cardiovascular Diseases
4
Warts
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Brain Neoplasms
3
Adenomatous Polyps
3
Pathologic Processes
2
Pain
2
Obesity
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Musculoskeletal Diseases
2
Melanoma
2
Male Urogenital Diseases
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Interventions
Cyclophosphamide
176
Rituximab
164
fludarabine phosphate
97
Peripheral Blood Stem Cell Transplantation
95
Filgrastim
73
Etoposide
67
Radiotherapy
63
Mycophenolic Acid
62
Whole-Body Irradiation
58
Tacrolimus
49
Melphalan
49
Cyclosporine
49
Busulfan
47
Lenalidomide
45
Antilymphocyte Serum
39
Vincristine
37
Prednisone
37
Cytarabine
37
fludarabine
35
Methotrexate
33
Carmustine
32
obinutuzumab
31
Doxorubicin
30
Bendamustine Hydrochloride
30
Methylprednisolone
27
ibritumomab tiuxetan
25
Cord Blood Stem Cell Transplantation
25
sargramostim
24
Bortezomib
24
Granulocyte Colony-Stimulating Factor
22
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, Follicular
×
Cholecalciferol
×
Clear all
NCT03078855
2024-09-04
ILyAD
University of Rochester
Phase 3
Completed
211 enrolled
13 charts
NCT05018988
2021-08-24
DVinCHI
University of Ulster
Phase NA
Unknown
118 enrolled